Murine models of acute and chronic lung infection with cystic fibrosis pathogens.
about
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung InfectionsCurrent progress of genetically engineered pig models for biomedical researchIL-37 inhibits inflammasome activation and disease severity in murine aspergillosisBarriers to inhaled gene therapy of obstructive lung diseases: A reviewModelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host responseFrom in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapy.Positive signature-tagged mutagenesis in Pseudomonas aeruginosa: tracking patho-adaptive mutations promoting airways chronic infectionAnti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis.mCLCA3 modulates IL-17 and CXCL-1 induction and leukocyte recruitment in murine Staphylococcus aureus pneumonia.Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hostsFactors contributing to epidemic MRSA clones replacement in a hospital setting.IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosaBacterial-induced epithelial damage promotes fungal biofilm formation in a sheep model of sinusitis.Heterogeneity in ess transcriptional organization and variable contribution of the Ess/Type VII protein secretion system to virulence across closely related Staphylocccus aureus strainsHost genetic background influences the response to the opportunistic Pseudomonas aeruginosa infection altering cell-mediated immunity and bacterial replication.Affecting Pseudomonas aeruginosa phenotypic plasticity by quorum sensing dysregulation hampers pathogenicity in murine chronic lung infection.Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection.Pseudomonas biofilm matrix composition and niche biologyPseudomonas aeruginosa in Dairy Goats: Genotypic and Phenotypic Comparison of Intramammary and Environmental Isolates.In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa.Comparative genomics and biological characterization of sequential Pseudomonas aeruginosa isolates from persistent airways infection.Efficacy of the Novel Antibiotic POL7001 in Preclinical Models of Pseudomonas aeruginosa Pneumonia.Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids.Genetic modifications of pigs for medicine and agriculture.Low sphingosine-1-phosphate impairs lung dendritic cells in cystic fibrosisIn vivo evidence of free radical generation in the mouse lung after exposure to Pseudomonas aeruginosa bacterium: an ESR spin-trapping investigationReduced caveolin-1 promotes hyperinflammation due to abnormal heme oxygenase-1 localization in lipopolysaccharide-challenged macrophages with dysfunctional cystic fibrosis transmembrane conductance regulator.Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.Requirement of the Pseudomonas aeruginosa CbrA sensor kinase for full virulence in a murine acute lung infection modelCell Biology Symposium: Zinc finger nucleases to create custom-designed modifications in the swine (Sus scrofa) genome.Staphylococcus aureus in early cystic fibrosis lung disease.Genetically modified pigs to model human diseases.Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections.Population Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar Rats.Insights into host-pathogen interactions from state-of-the-art animal models of respiratory Pseudomonas aeruginosa infections.Th17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines.Lentiviral Vector Gene Therapy Protects XCGD Mice From Acute Staphylococcus aureus Pneumonia and Inflammatory Response.Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections.Dissection of Host Susceptibility to Bacterial Infections and Its Toxins.
P2860
Q26768034-E8352ECA-C3F3-4D6E-A3F8-3C5F42A1F481Q27027327-99D5B3AA-ABBE-4714-BE3C-7D13BCD45B37Q28544789-E9FF0592-6550-4DD9-BC2A-72CFFF2CF19EQ29248141-1D454660-681D-4350-B4F8-6E0A74E5AFA9Q30394473-FFFE126B-9BAB-4644-A50B-2E314E452FE9Q30424697-A0C038A0-1A77-4404-B585-A9D238B65AA5Q33749315-6F3580CC-EB99-4B6C-B4E6-AE2536F944F8Q33815381-2ED74189-E793-4C0D-844B-F918F503B7FFQ33900765-D45DB46A-0E9F-4EA8-963F-F164FF345D8FQ33916302-81998CC5-FFB4-47E3-93F4-C204B9FE3A9BQ34256578-4AFB5B6E-B6EA-4A66-BECE-5156A815632FQ34384801-5FDA3D41-32BD-4F01-BBDD-DAB2BDF06431Q34527023-F33BB123-5162-4818-A195-3B37D259F517Q34544329-E1496B66-9733-4B2C-92F9-21D0DC799B98Q34842057-E5E7710C-FC7D-4CF1-9F6D-956BA77077F0Q35288221-BBDDA49C-6C08-460D-90B3-AD98061F3C55Q35446017-58C8BAC8-D48A-47E8-9029-BCA99FAD4EBCQ35513939-2C2B7874-5EE5-4C1D-814A-77D2BBD96EEAQ35538261-2B172BDB-0EE8-41DB-997F-9FAAC35CDDDDQ35852550-D5BA63B9-84A1-47AE-BE34-95BDE05CFBBBQ35859891-4C50EB74-C1ED-4150-95F8-26295F41265DQ35880930-4F397D41-E029-4A06-B7A1-57BCD2F6F713Q36051231-750B1880-14D0-4087-B1A3-E43C63CDAE73Q36355889-F24A2E9D-08A7-4C70-B920-79871C5A6308Q36466394-D1AA5484-E15A-47E3-8A7F-18EDA1F5BBBCQ36703926-F0480059-8BB7-4488-BB05-E3C2493C12F9Q36821102-40DB5F49-FF93-4FB4-B5FD-E55FBC632B11Q37011814-1A3B3172-CA17-49A2-AC8D-C11FD385E46AQ37223605-67562C32-8F89-4B2F-8EE2-4E88137428E9Q37643842-EE24BE98-FD6E-4588-B4D1-9F804BB88E71Q37950979-B7A5F664-FBFE-403E-9945-E419E5F58FFBQ38130897-5D7D250D-14F7-41ED-8A91-452536C958F7Q38162792-5354536C-7DA4-4BFD-A18C-4CB4244B6D52Q38522938-0F222AF1-4E3E-4DF8-A0C9-1C7866CB9430Q38810304-48D5A18E-4378-475B-A614-635097CA7890Q38978571-87B30EF0-ECE8-4EA1-A487-59AC10CEAD0CQ39488014-09B31DAD-F826-4487-A3BB-FA3C6EA7EBA1Q39561887-7C023AE7-73F2-4107-93FA-254613E21DD2Q40355789-3FBA8E77-FC97-4EA9-A4FD-2D5174BB5B39Q40416954-A3791CD8-E0DB-4C8D-BEEF-148B4F5837C1
P2860
Murine models of acute and chronic lung infection with cystic fibrosis pathogens.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Murine models of acute and chronic lung infection with cystic fibrosis pathogens.
@en
Murine models of acute and chronic lung infection with cystic fibrosis pathogens.
@nl
type
label
Murine models of acute and chronic lung infection with cystic fibrosis pathogens.
@en
Murine models of acute and chronic lung infection with cystic fibrosis pathogens.
@nl
prefLabel
Murine models of acute and chronic lung infection with cystic fibrosis pathogens.
@en
Murine models of acute and chronic lung infection with cystic fibrosis pathogens.
@nl
P1476
Murine models of acute and chronic lung infection with cystic fibrosis pathogens
@en
P2093
Alessandra Bragonzi
P304
P356
10.1016/J.IJMM.2010.08.012
P577
2010-10-14T00:00:00Z